13F HOLDINGS REPORT
Boxer Capital, LLC
Quarter ended Q4 2023 · Filed November 14, 2023 · Accession 0000895345-23-000631
Total Value
$1.88B
Positions
73
Other Managers
0
Confidential Omitted
No
Holdings (73)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Mirati Therapeutics Inc | 60468T105 | 3,201,440 | $139.5M | 7.42% |
| 2 | Revolution Medicines Inc | RVMDW | 4,684,264 | $129.7M | 6.90% |
| 3 | BeiGene Ltd | BEIGF | 500,000 | $89.9M | 4.79% |
| 4 | Tyra Biosciences Inc | TYRA | 6,448,359 | $88.8M | 4.73% |
| 5 | Akero Therapeutics Inc | 00973Y108 | 1,676,733 | $84.8M | 4.51% |
| 6 | Tango Therapeutics Inc | TNGX | 7,123,642 | $80.2M | 4.27% |
| 7 | Springworks Therapeutics Inc | 85205L107 | 3,421,541 | $79.1M | 4.21% |
| 8 | Sarepta Therapeutics Inc | SRPT | 600,000 | $72.7M | 3.87% |
| 9 | Apellis Pharmaceuticals Inc | APLS | 1,726,000 | $65.7M | 3.50% |
| 10 | Cytokinetics Inc | CYTK | 2,100,000 | $61.9M | 3.29% |
| 11 | Ideaya Biosciences Inc | IDYA | 2,202,812 | $59.4M | 3.16% |
| 12 | Nuvalent Inc | NUVL | 1,210,192 | $55.6M | 2.96% |
| 13 | ImmunoGen Inc | 45253H101 | 2,961,000 | $47.0M | 2.50% |
| 14 | Merus N V | N5749R100 | 1,900,000 | $44.8M | 2.38% |
| 15 | Karuna Therapeutics Inc | 48576A100 | 250,000 | $42.3M | 2.25% |
| 16 | Argenx SE | ARGX | 85,000 | $41.8M | 2.22% |
| 17 | Legend Biotech Corp | LEGN | 600,000 | $40.3M | 2.15% |
| 18 | Amylyx Pharmaceuticals Inc | AMLX | 2,084,000 | $38.2M | 2.03% |
| 19 | SPDR Ser Tr | 78464A870 | 500,000 | $36.5M | 1.94% |
| 20 | Prothena Corp PLC | PRTA | 625,000 | $30.2M | 1.61% |
| 21 | Rocket Pharmaceuticals Inc | RCKTW | 1,466,051 | $30.0M | 1.60% |
| 22 | Ventyx Biosciences Inc | 92332V107 | 850,000 | $29.5M | 1.57% |
| 23 | Immunovant Inc | IMVT | 750,000 | $28.8M | 1.53% |
| 24 | Arcus Biosciences Inc | RCUS | 1,602,200 | $28.8M | 1.53% |
| 25 | Amicus Therapeutics Inc | FOLD | 2,325,000 | $28.3M | 1.51% |
| 26 | Axsome Therapeutics Inc | AXSM | 400,000 | $28.0M | 1.49% |
| 27 | Exelixis Inc | EXEL | 1,150,000 | $25.1M | 1.34% |
| 28 | AnaptysBio Inc | ANABV | 1,300,000 | $23.3M | 1.24% |
| 29 | Sage Therapeutics Inc | 78667J108 | 1,094,000 | $22.5M | 1.20% |
| 30 | Viking Therapeutics Inc | VKTX | 2,000,000 | $22.1M | 1.18% |
| 31 | Xenon Pharmaceuticals Inc | XENE | 600,000 | $20.5M | 1.09% |
| 32 | iTeos Therapeutics Inc | 46565G104 | 1,804,058 | $19.8M | 1.05% |
| 33 | PMV Pharmaceuticals Inc | PMVP | 3,163,795 | $19.4M | 1.03% |
| 34 | Iovance Biotherapeutics Inc | IOVA | 3,705,133 | $16.9M | 0.90% |
| 35 | Point Biopharma Global Inc | 730541109 | 2,500,000 | $16.7M | 0.89% |
| 36 | Kalvista Pharmaceuticals Inc | KALV | 1,650,000 | $15.9M | 0.85% |
| 37 | Relay Therapeutics Inc | RLAY | 1,819,132 | $15.3M | 0.81% |
| 38 | Madrigal Pharmaceuticals Inc | MDGL | 100,000 | $14.6M | 0.78% |
| 39 | Day One Biopharmaceuticals I | DAWN | 1,189,943 | $14.6M | 0.78% |
| 40 | Oric Pharmaceuticals Inc | ORIC | 1,732,571 | $10.5M | 0.56% |
| 41 | Cullinan Oncology Inc | CGEM | 1,074,082 | $9.7M | 0.52% |
| 42 | Nurix Therapeutics Inc | NRIX | 1,224,892 | $9.6M | 0.51% |
| 43 | Acumen Pharmaceuticals Inc | ABOS | 2,206,983 | $9.2M | 0.49% |
| 44 | Zentalis Pharmaceuticals Inc | ZNTL | 450,000 | $9.0M | 0.48% |
| 45 | Ascendis Pharma A/S | ASND | 95,000 | $8.9M | 0.47% |
| 46 | Enliven Therapeutics Inc | ELVN | 646,058 | $8.8M | 0.47% |
| 47 | Prelude Therapeutics Inc | PRLD | 2,495,018 | $7.7M | 0.41% |
| 48 | Avidity Biosciences Inc | 05370A108 | 1,121,327 | $7.2M | 0.38% |
| 49 | Geron Corp | GERN | 3,000,000 | $6.4M | 0.34% |
| 50 | Gossamer Bio Inc | GOSS | 6,497,700 | $5.4M | 0.29% |
| 51 | Cogent Biosciences Inc | COGT | 525,000 | $5.1M | 0.27% |
| 52 | Centessa Pharmaceuticals PLC | CNTA | 770,708 | $5.0M | 0.27% |
| 53 | Rapt Therapeutics Inc | 75382E109 | 300,000 | $5.0M | 0.27% |
| 54 | Third Harmonic Bio Inc | 88427A107 | 520,417 | $3.3M | 0.18% |
| 55 | Mersana Therapeutics Inc | 59045L106 | 2,000,000 | $2.5M | 0.14% |
| 56 | EQRx Inc | 26886C107 | 1,000,000 | $2.2M | 0.12% |
| 57 | Orchestra Biomed Hldgs Inc | OBIO | 238,193 | $2.1M | 0.11% |
| 58 | 2Seventy Bio Inc | 901384107 | 459,836 | $1.8M | 0.10% |
| 59 | Black Diamond Therapeutics I | BDTX | 506,000 | $1.5M | 0.08% |
| 60 | DBV Technologies S A | DBVTF | 985,100 | $1.3M | 0.07% |
| 61 | BioAtla Inc | BCAB | 686,347 | $1.2M | 0.06% |
| 62 | Kodiak Sciences Inc | KOD | 600,000 | $1.1M | 0.06% |
| 63 | Fate Therapeutics Inc | FATE | 500,000 | $1.1M | 0.06% |
| 64 | Rain Oncology Inc | 75082Q105 | 1,152,212 | $992,976 | 0.05% |
| 65 | Milestone Pharmaceuticals In | MIST | 309,007 | $957,922 | 0.05% |
| 66 | Verrica Pharmaceuticals Inc | VRCA | 166,955 | $648,620 | 0.03% |
| 67 | Atreca Inc | 04965G109 | 2,202,333 | $574,809 | 0.03% |
| 68 | NGM Biopharmaceuticals Inc | 62921N105 | 500,000 | $535,000 | 0.03% |
| 69 | Theseus Pharmaceuticals Inc | 88369M101 | 150,000 | $403,500 | 0.02% |
| 70 | Protara Therapeutics Inc | TARA | 209,227 | $349,409 | 0.02% |
| 71 | Alaunos Therapeutics Inc | TCRT | 1,100,000 | $144,980 | 0.01% |
| 72 | Nuvation Bio Inc | NUVB | 266,666 | $26,667 | 0.00% |
| 73 | Surrozen Inc | SRZNW | 66,666 | $2,747 | 0.00% |